Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 13007-85-7
2. Gluceptate Sodium
3. Sodium Glucoheptonate
4. Sodium (2r,3r,4s,5r,6r)-2,3,4,5,6,7-hexahydroxyheptanoate
5. Sodium Gluceptate
6. Gluceptate Sodium [usan]
7. Glucoheptonic Acid Sodium Salt
8. H-quest C-100
9. 31138-65-5
10. Monosodium D-glycero-d-gulo-heptonate
11. Sodium .alpha.-glucoheptonate
12. Glucoheptonic Acid,sodium Salt
13. Sodium D-glycero-d-gulo-heptonate
14. 3d49le7hm2
15. Sodium .alpha.-d-glucoheptonate
16. Sodium Alpha-d-glucoheptonate
17. Sodium;(2r,3r,4s,5r,6r)-2,3,4,5,6,7-hexahydroxyheptanoate
18. Gluceptate Sodium (usan)
19. Sodium Alpha-glucoheptonate
20. Unii-3d49le7hm2
21. Einecs 235-849-8
22. D-gluco-heptonic Acid, Monosodium Salt
23. Monosodium Glucoheptonate
24. Dsstox_cid_7966
25. Ec 235-849-8
26. Dsstox_rid_78625
27. Dsstox_gsid_27966
28. Gluceptate Sodium [ii]
29. Schembl1479586
30. Chembl2106506
31. Sodium Gluceptate [inci]
32. Dtxsid50892018
33. Gluceptate Sodium [vandf]
34. Sodium D-glycero-d-guloheptanoate
35. Glucosecarboxylic Acid Sodium Salt
36. Gluceptate Sodium [who-dd]
37. Tox21_200936
38. Akos016009312
39. Ncgc00258490-01
40. Cas-31138-65-5
41. D-glycero-d-gulo-heptonic Acid Sodium Salt
42. Glucoheptonic Acid Sodium Salt [mi]
43. G0214
44. D04330
45. A806016
46. D-glycero-d-gulo-heptonic Acid, Sodium Salt (1:1)
47. Q27257058
| Molecular Weight | 248.16 g/mol |
|---|---|
| Molecular Formula | C7H13NaO8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 248.05081165 g/mol |
| Monoisotopic Mass | 248.05081165 g/mol |
| Topological Polar Surface Area | 162 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 213 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
36
PharmaCompass offers a list of 13007-85-7 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 13007-85-7 manufacturer or 13007-85-7 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 13007-85-7 manufacturer or 13007-85-7 supplier.
PharmaCompass also assists you with knowing the 13007-85-7 API Price utilized in the formulation of products. 13007-85-7 API Price is not always fixed or binding as the 13007-85-7 Price is obtained through a variety of data sources. The 13007-85-7 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 13007-85-7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 13007-85-7, including repackagers and relabelers. The FDA regulates 13007-85-7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 13007-85-7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 13007-85-7 supplier is an individual or a company that provides 13007-85-7 active pharmaceutical ingredient (API) or 13007-85-7 finished formulations upon request. The 13007-85-7 suppliers may include 13007-85-7 API manufacturers, exporters, distributors and traders.
13007-85-7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 13007-85-7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 13007-85-7 GMP manufacturer or 13007-85-7 GMP API supplier for your needs.
A 13007-85-7 CoA (Certificate of Analysis) is a formal document that attests to 13007-85-7's compliance with 13007-85-7 specifications and serves as a tool for batch-level quality control.
13007-85-7 CoA mostly includes findings from lab analyses of a specific batch. For each 13007-85-7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
13007-85-7 may be tested according to a variety of international standards, such as European Pharmacopoeia (13007-85-7 EP), 13007-85-7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (13007-85-7 USP).
